Get the Stockscreener App
85.67
1.41%
1.19
Prestige Consumer Healthcare Inc Stock (PBH) Forecast
The Prestige Consumer Healthcare Inc (PBH) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $92.86, representing a +8.39% increase from the current price of $85.67. The highest analyst price target is $95.27, and the lowest is $90.46.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PBH Price Target
Average 96.66
(+12.83% Upside)
Is Prestige Consumer Healthcare Inc (PBH) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 52.65 | Neutral |
| STOCH(9,6) | 24.46 | Neutral |
| STOCHRSI(14) | 25.23 | Neutral |
| MACD(12,26) | 0.5914 | Sell |
| ADX(14) | 13.46 | Neutral |
| William %R | -66.67 | Neutral |
| CCI(14) | -30.27 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
86.12
Sell
|
85.51
Buy
|
| MA20 |
85.63
Buy
|
85.17
Buy
|
| MA50 |
83.76
Buy
|
84.15
Buy
|
| MA100 |
82.74
Buy
|
82.72
Buy
|
| MA200 |
79.23
Buy
|
79.64
Buy
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, PBH could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 2 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on PBH, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 52.65 indicates that PBH is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 24.46 indicates that PBH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 25.23 indicates that PBH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 13.46 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -30.27 indicates that PBH is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term PBH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Prestige Consumer Healthcare Inc financial reports and earnings history, Prestige Consumer Healthcare Inc (PBH) stock could reach $112.69 by 2030, $304.99 by 2040 and $404.98 by 2050. See the projected annual prices until 2050 of the Prestige Consumer Healthcare Inc stock below:
- Prestige Consumer Healthcare Inc (PBH) is expected to reach an average price of $231.55 in 2035, with a high prediction of $233.13 and a low estimate of $229.41. This indicates an $170.28% rise from the last recorded price of $85.67.
- Prestige Consumer Healthcare Inc (PBH) stock is projected to chart a bullish course in 2040, with an average price target of $303.50, representing an $254.27% surge from its current level. The forecast ranges from a conservative $302.43 to a sky-high $304.99.
- Our analysts predict Prestige Consumer Healthcare Inc (PBH) to jump 307.68% by 2045, soaring from $347.32 to an average price of $349.26, potentially reaching $351.26. While $347.32 is the low estimate, the potential upside is significant.
- Prestige Consumer Healthcare Inc (PBH) stock is expected to climb by 2050, reaching an average of $400.99, a $368.06% jump from its current level. However, a wide range of estimates exists, with high and low targets of $404.98 and $399.64, respectively, highlighting the market's uncertainty.
Prestige Consumer Healthcare Inc Stock (PBH) Year by Year Forecast
Prestige Consumer Healthcare Inc Stock (PBH) Price Forecast for 2025
Prestige Consumer Healthcare Inc Stock (PBH) is expected to reach an average price of $85.83 in 2025, with a high prediction of $95.62 and a low estimate of $76.05. This indicates an +0.19% rise from the last recorded price of $85.67.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $91.10 | $90.46 | $95.27 | +6.34% |
| August, 2025 | $88.47 | $86.58 | $91.31 | +3.27% |
| September, 2025 | $92.57 | $88.34 | $95.62 | +8.06% |
| October, 2025 | $90.35 | $89.10 | $92.95 | +5.46% |
| November, 2025 | $90.63 | $87.91 | $91.34 | +5.79% |
| December, 2025 | $88.11 | $87.28 | $92.39 | +2.85% |
Prestige Consumer Healthcare Inc Stock (PBH) Price Forecast for 2026
The predicted value for Prestige Consumer Healthcare Inc (PBH) in 2026 is set at an average of $105.83. Estimates vary from a peak of $123.54 to a trough of $88.12, indicating an +23.53% surge from the present price of $85.67.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $92.45 | $88.12 | $92.98 | +7.92% |
| February, 2026 | $92.63 | $91.30 | $94.30 | +8.12% |
| March, 2026 | $94.71 | $90.92 | $95.43 | +10.55% |
| April, 2026 | $99.39 | $94.55 | $103.18 | +16.02% |
| May, 2026 | $104.59 | $98.72 | $106.74 | +22.09% |
| June, 2026 | $103.22 | $102.01 | $105.26 | +20.49% |
| July, 2026 | $108.84 | $103.13 | $109.29 | +27.04% |
| August, 2026 | $112.79 | $108.65 | $112.81 | +31.66% |
| September, 2026 | $113.64 | $112.32 | $115.07 | +32.64% |
| October, 2026 | $121.38 | $113.22 | $122.10 | +41.68% |
| November, 2026 | $120.71 | $118.98 | $123.54 | +40.90% |
| December, 2026 | $120.32 | $115.81 | $121.78 | +40.45% |
Prestige Consumer Healthcare Inc Stock (PBH) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Prestige Consumer Healthcare Inc (PBH) is $127.41, with a high forecast of $135.13 and a low forecast of $119.69. This indicates an +48.72% increase from the last price of $85.67.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $124.11 | $119.69 | $124.49 | +44.87% |
| February, 2027 | $123.85 | $123.33 | $129.20 | +44.57% |
| March, 2027 | $125.57 | $121.00 | $126.85 | +46.57% |
| April, 2027 | $126.82 | $125.35 | $130.29 | +48.03% |
| May, 2027 | $126.20 | $123.18 | $130.61 | +47.31% |
| June, 2027 | $127.84 | $124.54 | $129.99 | +49.22% |
| July, 2027 | $122.39 | $121.92 | $128.22 | +42.86% |
| August, 2027 | $123.39 | $121.50 | $125.66 | +44.03% |
| September, 2027 | $127.25 | $122.20 | $129.44 | +48.54% |
| October, 2027 | $126.49 | $124.63 | $128.60 | +47.65% |
| November, 2027 | $131.10 | $126.17 | $133.20 | +53.02% |
| December, 2027 | $130.03 | $129.83 | $135.13 | +51.78% |
Prestige Consumer Healthcare Inc Stock (PBH) Price Forecast for 2028
In 2028, Prestige Consumer Healthcare Inc (PBH) is projected to reach an average price of $134.29, with a high projection of $145.37 and a low estimate of $123.21. This indicates an +56.75% rise from the last price of $85.67.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $124.48 | $124.11 | $130.59 | +45.30% |
| February, 2028 | $124.53 | $123.21 | $128.20 | +45.36% |
| March, 2028 | $130.06 | $123.88 | $131.22 | +51.81% |
| April, 2028 | $136.66 | $127.75 | $137.38 | +59.52% |
| May, 2028 | $139.17 | $136.16 | $140.54 | +62.45% |
| June, 2028 | $144.58 | $139.16 | $145.31 | +68.76% |
| July, 2028 | $138.16 | $136.99 | $145.37 | +61.27% |
| August, 2028 | $138.65 | $137.61 | $140.89 | +61.84% |
| September, 2028 | $143.49 | $138.15 | $143.76 | +67.49% |
| October, 2028 | $141.59 | $140.01 | $144.90 | +65.28% |
| November, 2028 | $140.21 | $138.24 | $142.61 | +63.66% |
| December, 2028 | $141.84 | $134.78 | $142.41 | +65.57% |
Prestige Consumer Healthcare Inc Stock (PBH) Price Forecast for 2029
The 2029 price forecast for Prestige Consumer Healthcare Inc Stock (PBH) is $136.52 on average, with a high prediction of $165.43 and a low estimate of $107.61. This represents an +59.35% increase from the previous price of $85.67.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $148.50 | $139.85 | $149.18 | +73.33% |
| February, 2029 | $144.22 | $142.61 | $152.17 | +68.34% |
| March, 2029 | $142.57 | $140.90 | $144.81 | +66.41% |
| April, 2029 | $144.80 | $141.56 | $145.44 | +69.02% |
| May, 2029 | $143.95 | $143.32 | $147.52 | +68.03% |
| June, 2029 | $145.57 | $143.40 | $146.52 | +69.92% |
| July, 2029 | $148.88 | $145.44 | $150.16 | +73.79% |
| August, 2029 | $150.08 | $145.79 | $152.10 | +75.18% |
| September, 2029 | $158.96 | $148.89 | $159.24 | +85.55% |
| October, 2029 | $163.37 | $158.18 | $165.43 | +90.69% |
| November, 2029 | $160.49 | $158.27 | $163.90 | +87.33% |
| December, 2029 | $111.14 | $107.61 | $163.39 | +29.73% |
Prestige Consumer Healthcare Inc Stock (PBH) Price Forecast for 2030
Prestige Consumer Healthcare Inc Stock (PBH) is expected to reach an average price of $124.94 in 2030, with a high forecast of $140.31 and a low forecast of $109.57. This signifies an +45.84% surge from the last price of $85.67.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $112.37 | $109.57 | $112.69 | +31.17% |
| February, 2030 | $114.18 | $112.25 | $115.43 | +33.28% |
| March, 2030 | $118.06 | $113.38 | $120.44 | +37.81% |
| April, 2030 | $117.80 | $116.76 | $119.57 | +37.50% |
| May, 2030 | $122.62 | $117.61 | $123.64 | +43.13% |
| June, 2030 | $124.27 | $121.44 | $125.53 | +45.05% |
| July, 2030 | $128.20 | $123.09 | $128.84 | +49.64% |
| August, 2030 | $132.40 | $128.73 | $133.10 | +54.55% |
| September, 2030 | $132.05 | $131.75 | $134.85 | +54.14% |
| October, 2030 | $138.07 | $132.45 | $140.31 | +61.16% |
| November, 2030 | $129.76 | $128.88 | $139.48 | +51.46% |
| December, 2030 | $134.91 | $124.65 | $136.86 | +57.47% |
18.36%
0.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):